Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Coya Therapeutics Inc (COYA)

  • SEC News
  • Jan. 20, 2026, 13:20 UTC
  • 0
  • 1 comments

(99% Neutral) Coya Therapeutics Inc (COYA) Announces Clinical Development Update

Comment Full text

NovaBay Pharmaceuticals Inc. (NBY)

  • SEC News
  • Jan. 20, 2026, 13:16 UTC
  • 6
  • 0 comments

New Form 424B5 - NovaBay Pharmaceuticals, Inc. Filed: 2026-01-20 AccNo: 0001437749-26-001489 Size: 498 KB

Comment Full text

NovaBay Pharmaceuticals Inc. (NBY)

  • SEC News
  • Jan. 20, 2026, 13:16 UTC
  • 0
  • 1 comments

(99% Neutral) NovaBay Pharmaceuticals Inc. (NBY) Announces Business Combination

Comment Full text

Acadia Healthcare Company Inc (ACHC)

  • SEC News
  • Jan. 20, 2026, 13:06 UTC
  • 0
  • 1 comments

(97% Neutral) Acadia Healthcare Company Inc (ACHC) Announces Business Combination

Comment Full text

Moleculin Biotech Inc. (MBRX)

  • SEC News
  • Jan. 20, 2026, 13:00 UTC
  • 0
  • 1 comments

(99% Neutral) Moleculin Biotech Inc. (MBRX) Files Form 8-K

Comment Full text

LakeShore Biopharma Co., Ltd s (LSBPW)

  • SEC News
  • Jan. 20, 2026, 12:44 UTC
  • 6
  • 0 comments

New Form SC 13E3/A - LakeShore Biopharma Co., Ltd. Filed: 2026-01-20 AccNo: 0001213900-26-005369 Size: 1 MB

Comment Full text

RAPT Therapeutics Inc (RAPT)

  • SEC News
  • Jan. 20, 2026, 12:25 UTC
  • 5
  • 0 comments

New Form SC14D9C - RAPT Therapeutics, Inc. Filed: 2026-01-20 AccNo: 0001193125-26-015978 Size: 90 KB

Comment Full text

Cardinal Health Inc (CAH)

  • SEC News
  • Jan. 20, 2026, 12:21 UTC
  • 0
  • 1 comments

Pitteroff Valerie Christine 🟢 acquired 4.0K shares of CARDINAL HEALTH INC (CAH) at $213.26 Transaction Date: Jan 15, 2026 | Filing ID: 000004

Comment Full text

908 Devices Inc (MASS)

  • SEC News
  • Jan. 20, 2026, 12:15 UTC
  • 0
  • 1 comments

(100% Positive) 908 Devices Inc (MASS) Reports Q1 2026 Financial Results

Comment Full text

RAPT Therapeutics Inc (RAPT)

  • SEC News
  • Jan. 20, 2026, 12:13 UTC
  • 6
  • 0 comments

New Form SC14D9C - RAPT Therapeutics, Inc. Filed: 2026-01-20 AccNo: 0001193125-26-015962 Size: 21 KB

Comment Full text
  • Previous
  • 74
  • 75
  • 76
  • 77
  • 78
  • Next

Search

News categories

  • Technical Exchange News(10866)
  • Event(2236)
  • SEC News(188613)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(124420)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin